Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWOG S9900: Preoperative Paclitaxel/Carboplatin vs Surgery in Early Stage NSCLC
NCT00004011Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Oct 1999
- Primary completion
- May 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 3 trial of paclitaxel, carboplatin in non-small cell lung cancer (NSCLC), sponsored by SWOG Cancer Research Network. Started Oct 1999; status: completed.
02
Drugs
paclitaxelcarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00004011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004011.